Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideoOut 100
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The Food and Drug Administration approved the first single-capsule, once-a-day protease inhibitor in late October. Reyataz is now available in 300-milligram form, to be boosted with Norvir. ----- The French National Agency for Research on AIDS has released study results that show the risk of mother-to-child HIV transmission can be greatly reduced by combining treatment of AZT and lamivudine at the end of pregnancy and during delivery with alternatives to breast feeding. ----- Boehringer-Ingelheim has halted a three-year study of protease inhibitor Aptivus among treatment-naive HIVers because of poor viral control. The proportion of study subjects who achieved a viral load below 50 after 48 weeks of treatment with 500 milligrams of Aptivus plus a booster dose of Norvir was more than 15% lower than those taking Kaletra. ----- Protease inhibitors Lexiva and Kaletra are similar in safety and effectiveness, according to a 48-week, 878-patient study published in the August 5 edition of The Lancet, leading researchers to conclude that Lexiva could soon be considered a preferred protease option on par with Kaletra. ----- A three-year study of 765 patients reported in The Journal of the American Medical Association has found no advantage in adding a fourth drug to the standard three-drug cocktail for treating newly diagnosed HIV patients. Researchers gave two groups of treatment-naive patients each a regimen containing five pills daily. The researchers found the four-drug cocktail, which added abacavir, offered no benefit over the three-drug cocktail either in terms of reduced viral load or increased CD4-cell count.
Want more breaking equality news & trending entertainment stories?
Check out our NEW 24/7 streaming service: the Advocate Channel!
Download the Advocate Channel App for your mobile phone and your favorite streaming device!
From our Sponsors
Most Popular
Plus: Featured Video
Latest Stories
Shop Your Pride: Dive into LGBTQ+ & Ally Brands with The Grand Opening of The Pride Store
November 28 2023 5:32 PM
These Black Queer Podcasts (Featuring Literally Zero Cis White Gay Men) Deserve Your Ears
November 28 2023 11:55 AM
7 Uplifting Films To Celebrate Trans Awareness Week & Where To Stream Them
November 17 2023 10:25 AM
Out's Deal Guide: Grab Your 50% Off Amazon Fire Tablets & More Recommended Deals on Amazon Today!
November 03 2023 3:44 PM
Unlock Massive Savings at 'The Holiday Shop': Amazon's Hottest Deals of the Season Await!
November 02 2023 2:17 PM
Dianne Feinstein’s Commitment to People Living With HIV Won’t Be Forgotten
November 02 2023 1:27 PM
PEPFAR in Peril: The Far-Right Wants to End the Lifesaving Global HIV Program
October 24 2023 1:52 PM
Trending stories
Most Recent
Recommended Stories for You
HIV Plus Editors
Editor
Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.
Ryan is the Digital Director of The Advocate Channel, and a graduate of NYU Tisch's Department of Dramatic Writing. She is also a member of GALECA, the LGBTQ+ society of entertainment critics. While her specialties are television writing and comedy, Ryan is a young member of the LGBTQ+ community passionate about politics and advocating for all.